These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 16277887

  • 1. Treatment of metastatic breast cancer with trastuzumab and vinorelbine during pregnancy.
    Fanale MA, Uyei AR, Theriault RL, Adam K, Thompson RA.
    Clin Breast Cancer; 2005 Oct; 6(4):354-6. PubMed ID: 16277887
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of breast cancer with trastuzumab during pregnancy.
    Pant S, Landon MB, Blumenfeld M, Farrar W, Shapiro CL.
    J Clin Oncol; 2008 Mar 20; 26(9):1567-9. PubMed ID: 18349415
    [No Abstract] [Full Text] [Related]

  • 4. A case study of trastuzumab treatment for metastatic breast cancer in pregnancy: fetal risks and management of cerebral metastases.
    Mandrawa CL, Stewart J, Fabinyi GC, Walker SP.
    Aust N Z J Obstet Gynaecol; 2011 Aug 20; 51(4):372-6. PubMed ID: 21806575
    [Abstract] [Full Text] [Related]

  • 5. Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm.
    Burstein HJ, Harris LN, Marcom PK, Lambert-Falls R, Havlin K, Overmoyer B, Friedlander RJ, Gargiulo J, Strenger R, Vogel CL, Ryan PD, Ellis MJ, Nunes RA, Bunnell CA, Campos SM, Hallor M, Gelman R, Winer EP.
    J Clin Oncol; 2003 Aug 01; 21(15):2889-95. PubMed ID: 12885806
    [Abstract] [Full Text] [Related]

  • 6. Re-evaluation of HER2 status in metastatic breast cancer and tumor-marker guided therapy with vinorelbine and trastuzumab.
    Stemmler HJ, Stieber P, Lässig D, Heinemann V.
    Onkologie; 2005 Feb 01; 28(2):95-7. PubMed ID: 15692222
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T, Inoue K, Nagamoto N, Yoshida Y, Nakahara O.
    Gan To Kagaku Ryoho; 2006 Sep 01; 33(9):1301-3. PubMed ID: 16969029
    [Abstract] [Full Text] [Related]

  • 9. Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy.
    Chen JH, Mehta RS, Carpenter PM, Nalcioglu O, Su MY.
    J Clin Oncol; 2007 Dec 10; 25(35):5667-9. PubMed ID: 18065744
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Markedly effective regimen using bi-weekly trastuzumab and paclitaxel in an advanced breast cancer with multiple liver metastases].
    Rai Y, Takahama T, Sagara Y, Sagara Y, Matsuyama Y, Ando M, Sagara Y, Ooi Y.
    Gan To Kagaku Ryoho; 2006 Sep 10; 33(9):1297-300. PubMed ID: 16969028
    [Abstract] [Full Text] [Related]

  • 13. [Effective combination chemotherapy using weekly trastuzumab and paclitaxel in the treatment of a recurrent breast cancer patient with liver metastases].
    Tohnosu N, Kobayashi Y, Saito T, Shimizu T, Natsume T, Tanaka H, Maruyama T, Watanabe Y.
    Gan To Kagaku Ryoho; 2003 Jul 10; 30(7):989-92. PubMed ID: 12894716
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups.
    Untch M, Fasching PA, Konecny GE, Hasmüller S, Lebeau A, Kreienberg R, Camara O, Müller V, du Bois A, Kühn T, Stickeler E, Harbeck N, Höss C, Kahlert S, Beck T, Fett W, Mehta KM, von Minckwitz G, Loibl S.
    J Clin Oncol; 2011 Sep 01; 29(25):3351-7. PubMed ID: 21788566
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
    Kerr JR.
    Pharmacotherapy; 2005 Mar 01; 25(3):438-41. PubMed ID: 15843292
    [Abstract] [Full Text] [Related]

  • 19. [Bi-weekly nab-paclitaxel and trastuzumab therapy effective against recurrent breast cancer with multiple lung metastases in elderly patient who had previously undergone two chemotherapeutic regimens for treatment of metastatic disease-a case Report].
    Sakurai T, Jinta E, Suzuma T, Yoshimura G, Umemura T, Sakurai T.
    Gan To Kagaku Ryoho; 2012 Nov 01; 39(11):1703-6. PubMed ID: 23152023
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.